DMPK Strategy Director: Lead NDA-Ready Programs

Eli Lilly and Company is seeking a Senior Director, DMPK Project Leader to drive end-to-end DMPK activities within a cross-functional program team. You will oversee nonclinical PK, in vitro ADME, biotransformation studies, and toxicokinetic analysis to enable progression of CNS drug candidates.
Ideal candidates will have a Ph.D. and 10+ years in biotech/pharma, with NDA experience and proficiency in PK modeling tools like Phoenix WinNonlin. The role is based in the US with travel.

#J-18808-Ljbffr